Venkatakrishna R Jala - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Venkatakrishna R Jala

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

Molecular Cancer Therapeutics|November 9, 2018

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.

Mucosal Immunology|April 10, 2026

The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.

Journal of Hepatology|May 28, 2018

Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunctionTuo Shao, Cuiqing Zhao, Fengyuan Li, et al.

Nature Communications|January 11, 2019

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathwayRajbir Singh, Sandeep Chandrashekharappa, Sobha R Bodduluri, et al.

Pageof 6

Search research articles

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

Molecular Cancer Therapeutics|November 9, 2018

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic CancerTulasigeri M Totiger, Supriya Srinivasan, Venkatakrishna R Jala, et al.

Mucosal Immunology|April 10, 2026

The Nox2 NADPH oxidase regulates neutrophilic inflammation in the oral cavityShunying Jin, Richa Singhal, Jianzhu Luo, et al.

Journal of Hepatology|May 28, 2018

Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunctionTuo Shao, Cuiqing Zhao, Fengyuan Li, et al.

Nature Communications|January 11, 2019

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathwayRajbir Singh, Sandeep Chandrashekharappa, Sobha R Bodduluri, et al.

Pageof 6